Failure to Diagnose Colon Cancer: A Case-Screening Guide

Cancers are one of the "Big Three" categories of serious diagnostic error, and delayed colorectal-cancer diagnosis is among the most common reasons for ambulatory (outpatient) diagnostic malpractice claims in the United States. The disease is unusually well-suited to early detection — it grows slowly, screening works, and the warning signs are concrete — which is exactly why a missed one is so costly: the failure is almost always a missed clue that sat in the chart, not a hidden, unpredictable tumor.

Frequency & severity

Colorectal cancer is one of the leading causes of cancer death in the United States, and it is also one of the most preventable through screening and timely workup of symptoms. Because it typically progresses over months to years, a delay in acting on a warning sign frequently produces a clear stage shift — from a localized, highly curable cancer to a node-positive or metastatic one. Incidence in younger adults has been rising, which compounds the danger of the "too young for colon cancer" anchoring bias. The harm in these cases is severe and the damages substantial because the delay so often converts a curable cancer into a fatal one.

The cannot-miss clinical picture & red flags

The litigated colon-cancer case is built on warning signs that were documented and dismissed. The red flags:

• Unexplained iron-deficiency anemia — the single most important and most commonly missed clue, especially in older adults and in any man or postmenopausal woman without an obvious bleeding source. Right-sided cancers bleed slowly and silently and may present only as anemia.
• Rectal bleeding or blood in the stool — routinely and wrongly attributed to hemorrhoids, often without a digital rectal exam or any further workup.
• A persistent change in bowel habits — new constipation, diarrhea, narrowing of stool, or a change written off as "IBS" without ruling out malignancy.
• Unexplained weight loss, abdominal pain, or a palpable mass.
• A positive stool-based screening test (FIT/FOBT) or Cologuard that was never followed by the indicated colonoscopy.
• A family history or other risk factors that should have lowered the screening age and the threshold to scope.

The recurring standard-of-care principle: unexplained iron-deficiency anemia, a positive screening test, or rectal bleeding not clearly explained by a benign source generally warrants colonoscopy, not reassurance. The most-dismissed symptom is rectal bleeding labeled "hemorrhoids" without an examination — and anemia is associated with some of the longest delays to endoscopic referral in the published literature.

Dominant allegation types

• Dismissing rectal bleeding as hemorrhoids — no rectal exam, no colonoscopy referral, particularly in a patient over the screening age or with risk factors.
• Failure to work up unexplained iron-deficiency anemia — iron pills prescribed, the cause never investigated, no endoscopy.
• Failure to act on a positive screening test — a positive FIT/FOBT or Cologuard that was never followed by colonoscopy, often a tracking/loop-closure failure.
• Anchoring on IBS or another benign label — persistent symptoms attributed to a functional disorder without ruling out cancer.
• Failure to screen on schedule — an average-risk patient past the guideline age, or a high-risk patient, never referred for screening.

What makes a strong vs. weak case

A strong case usually has a documented clue, a clear failure to act, and a meaningful stage difference:

• Breach: a charted red flag — iron-deficiency anemia, rectal bleeding, a positive screening test, or a worrisome change in bowel habits — that the standard of care required to be worked up with colonoscopy, and a record showing it was not done, not referred, or not tracked.
• Causation: proof that timely workup would more likely than not have caught the cancer at an earlier, more curable stage — or, in loss-of-chance jurisdictions, materially improved the chance of cure.
• Damages: more aggressive treatment, reduced survival, recurrence, or death.

A weak or defensible case typically involves a short delay that did not change stage; a benign-appearing presentation that was reasonably worked up; an aggressive cancer where earlier diagnosis would not have changed the outcome; or significant patient non-adherence — a refused or repeatedly no-showed colonoscopy, declined screening, or ignored referral. Because the damages depend on what the delay cost in staging, an oncology causation analysis tied to the tumor's location, biology, and the length of the delay is essential.

Contributing factors

Recurring factors include the reflexive "it's just hemorrhoids" framing of rectal bleeding without an exam; treating iron-deficiency anemia as a problem to supplement rather than investigate; broken result-tracking that drops positive screening tests and never books the follow-up colonoscopy; the "too young" bias as colorectal cancer rises in younger adults; and fragmented care across primary care, gastroenterology, and screening programs where no one owns the loop.

The records angle

The chart should establish when the first clue appeared (the first abnormal hemoglobin/ferritin, the first report of bleeding, the first positive screening test), whether a digital rectal exam was done, what was ordered in response, whether a colonoscopy was referred and whether it actually happened, and how abnormal results and referrals were tracked and communicated. A precise chronology aligning the first documented clue against the eventual diagnosis defines the delay interval; the lab trends, pathology, and staging anchor causation; and the EHR audit trail confirms when entries were made and whether anything was amended after diagnosis.

The bottom line

The viable delayed-colon-cancer case is usually a missed-clue case: anemia that was supplemented but never investigated, or bleeding that was called hemorrhoids without an exam, while a curable cancer advanced over months. If the record shows a red flag the standard of care required to be worked up with colonoscopy, a workup that was never done or never tracked, and a cancer that timely diagnosis more likely than not would have caught at a curable stage, the breach, causation, and damages can all be built from the chart, the lab trends, and the staging data.

General information for attorneys, not legal or medical advice. Standard-of-care, causation, and damages rules vary by jurisdiction — verify every standard, statute, and deadline against current authority in your venue, and rely on a qualified medical expert for the clinical analysis.

Questions? [email protected] · (856) 979-6525